drugset / Trial / NCT00002345

The Safety and Effectiveness of Megace in HIV-Infected Women

NCT00002345

Phase 4 Completed 40 enrolled Bristol-Myers Squibb
RandomizedTreatment

Summary

To further evaluate the safety of megestrol acetate (Megace) oral suspension in the treatment of anorexia and cachexia in HIV-positive women. To compare the effectiveness of 2 doses of Megace by measurement of weight gain, appetite grade, and other parameters at 12 and 24 weeks.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Megestrol Acetate Other / unclassified Oral